Journal Article Summary

The article investigates the effectiveness of tamper-resistant formulations (TRFs) of tapentadol in comparison to OxyContin, a commonly abused opioid. The study is significant because prescription opioids are widely used for pain relief but also have a high potential for abuse, leading to public health concerns. By exploring whether TRFs can deter tampering and abuse, the research aims to contribute to strategies that could reduce the misuse of these medications while still providing effective pain management.

The researchers conducted two studies with 25 participants each, all of whom were experienced abusers of OxyContin. In the first study, they assessed the willingness of participants to snort tampered tablets, while the second study focused on the ability to extract active drug for injection. The findings revealed that a significantly lower percentage of participants were willing to snort or inject the TRF tapentadol tablets compared to OxyContin, indicating that the TRFs were less desirable for abuse. Additionally, the TRF tablets produced larger, less usable particles, which further reduced their appeal for tampering.

Despite these promising results, the study has limitations, including the reliance on self-reported data, which may not accurately reflect actual behaviors in real-life situations. Patients and caregivers should discuss the risks and benefits of using tamper-resistant formulations with healthcare professionals, especially considering the potential for misuse and the safety concerns associated with tampering. Understanding these factors can help inform decisions about pain management and the use of prescription opioids.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication. Always consult a licensed healthcare professional before using a medical device.

Article Cited

  1. Vosburg Suzanne K., Jones Jermaine D., Manubay Jeanne M., Ashworth Judy B., Shapiro Douglas Y., Comer Sandra D.. A comparison among tapentadol tamper-resistant formulations (TRF) and OxyContin® (non-TRF) in prescription opioid abusers. Addiction (Abingdon, England) 2013. DOI: 10.1111/add.12114. PMID: 23316699. PMCID: PMC3664924.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]